Arbor Biotechnologies to Present at the 40th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, MA - January 10, 2022 -

Arbor Biotechnologies^®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its participation in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

Arbor’s CEO, Devyn Smith, Ph.D., will present a corporate overview virtually on Wednesday, January 12, 2022 at 1:00 p.m. PST (4:00 p.m. EST).